Literature DB >> 30573414

Parkinson's disease in Nigeria: A review of published studies and recommendations for future research.

Oluwafemi G Oluwole1, Helena Kuivaniemi1, Jonathan A Carr2, Owen A Ross3, Matthew O B Olaogun4, Soraya Bardien5, Morenikeji A Komolafe6.   

Abstract

Parkinson's disease (PD) affects 1-2% of individuals above 60 years amounting to over 7 million people worldwide. Thus, PD has become an important contributor to the neurological disease burden. Nigeria is the most populous country in Africa, and alarmingly, approximately 5.25 million Nigerians are above 65 years and are therefore at risk for developing PD. We carried out a critical review of published literature on PD in Nigeria to summarize the findings and to evaluate gaps in knowledge. Seven electronic databases were searched for studies published in English before 18th July 2018. Search terms were ["Parkinson's disease" OR "Parkinson disease" OR "parkinsonian disorders" OR "Parkinsonism"] AND "Nigeria". A total of 44 articles (including eight reviews) published since 1969 were identified and reviewed. Amongst the original research articles, most (23) were on PD symptoms or prevalence. There were only two studies on genetics and two on environmental factors. The estimated crude prevalence of PD in Nigeria was lower (10-249/100 000) compared to studies published in Europe (65.6-12 500/100 000). Our findings suggest that PD is under-diagnosed in Nigeria. Possible environmental risk factors identified include blacksmithing and well-water contaminated with trace metals. Given the rising numbers of the ageing population in Nigeria, more studies to evaluate the prevalence and causes of PD in this country are urgently needed. To this end, more funding, resources and a workforce of well-trained neurologists and scientists are essential to manage the impending health burden of PD and related disorders in this country.
Copyright © 2018. Published by Elsevier Ltd.

Entities:  

Keywords:  Nigeria; Parkinson's disease; Parkinsonism; Prevalence; Risk factors; Symptoms

Mesh:

Year:  2018        PMID: 30573414      PMCID: PMC6556138          DOI: 10.1016/j.parkreldis.2018.12.004

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  49 in total

1.  Neurological disorders in Nigerian Africans: a community-based study.

Authors:  B O Osuntokun; A O Adeuja; B S Schoenberg; O Bademosi; V A Nottidge; A O Olumide; O Ige; F Yaria; C L Bolis
Journal:  Acta Neurol Scand       Date:  1987-01       Impact factor: 3.209

2.  Plasma homocysteine as a risk factor for dementia and Alzheimer's disease.

Authors:  Sudha Seshadri; Alexa Beiser; Jacob Selhub; Paul F Jacques; Irwin H Rosenberg; Ralph B D'Agostino; Peter W F Wilson; Philip A Wolf
Journal:  N Engl J Med       Date:  2002-02-14       Impact factor: 91.245

3.  Incidental Lewy body disease in black Africans.

Authors:  K Jendroska; B J Olasode; S E Daniel; L Elliott; A O Ogunniyi; P U Aghadiuno; B O Osuntokun; A J Lees
Journal:  Lancet       Date:  1994-09-24       Impact factor: 79.321

Review 4.  Neuroimaging in Parkinsonian Disorders.

Authors:  Madhavi Tripathi; Atin Kumar; Chandrasekhar Bal
Journal:  Neurol India       Date:  2018 Mar-Apr       Impact factor: 2.117

Review 5.  The prevalence and genetics of Parkinson's disease in sub-Saharan Africans.

Authors:  Janine Blanckenberg; Soraya Bardien; Brigitte Glanzmann; Njideka U Okubadejo; Jonathan A Carr
Journal:  J Neurol Sci       Date:  2013-09-15       Impact factor: 3.181

Review 6.  Epidemiology of Parkinson's disease.

Authors:  Lonneke M L de Lau; Monique M B Breteler
Journal:  Lancet Neurol       Date:  2006-06       Impact factor: 44.182

7.  Relationship between cognitive dysfunction and behavioural symptoms in Nigerian patients with Parkinson's disease no dementia.

Authors:  Akin Ojagbemi
Journal:  J Parkinsons Dis       Date:  2013-01-01       Impact factor: 5.568

8.  Cognitive dysfunction in Nigerians with Parkinson's disease.

Authors:  Rufus O Akinyemi; Njideka N Okubadejo; Joshua O Akinyemi; Mayowa O Owolabi; Lukman F Owolabi; Adesola Ogunniyi
Journal:  Mov Disord       Date:  2008-07-30       Impact factor: 10.338

9.  Frequency of cognitive impairment and depression in Parkinson's disease: A preliminary case-control study.

Authors:  Oluwadamilola O Ojo; Njideka U Okubadejo; Frank I Ojini; Mustapha A Danesi
Journal:  Niger Med J       Date:  2012-04

10.  Clinical profile of parkinsonism and Parkinson's disease in Lagos, Southwestern Nigeria.

Authors:  Njideka U Okubadejo; Oluwadamilola O Ojo; Olajumoke O Oshinaike
Journal:  BMC Neurol       Date:  2010-01-05       Impact factor: 2.474

View more
  3 in total

1.  Early-Onset Parkinson Disease Screening in Patients From Nigeria.

Authors:  Lukasz M Milanowski; Olajumoke Oshinaike; Benjamin J Broadway; Jennifer A Lindemann; Alexandra I Soto-Beasley; Ronald L Walton; Rana Hanna Al-Shaikh; Audrey J Strongosky; Fabienne C Fiesel; Owen A Ross; Wolfdieter Springer; Shamsideen Abayomi Ogun; Zbigniew K Wszolek
Journal:  Front Neurol       Date:  2021-01-14       Impact factor: 4.003

Review 2.  Neurodegenerative Diseases: Implications of Environmental and Climatic Influences on Neurotransmitters and Neuronal Hormones Activities.

Authors:  Emmanuel A Ayeni; Ahmad M Aldossary; Daniel A Ayejoto; Lanre A Gbadegesin; Abdullah A Alshehri; Haya A Alfassam; Henok K Afewerky; Fahad A Almughem; Saidu M Bello; Essam A Tawfik
Journal:  Int J Environ Res Public Health       Date:  2022-09-30       Impact factor: 4.614

Review 3.  Management of Iron Overload in Resource Poor Nations: A Systematic Review of Phlebotomy and Natural Chelators.

Authors:  Orish Ebere Orisakwe; Cecilia Nwadiuto Amadi; Chiara Frazzoli
Journal:  J Toxicol       Date:  2020-01-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.